Llwytho...
Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer
Until recently, treatment for metastatic melanoma was characterised by a limited availability of treatment options that offer objective survival benefit. Cytotoxic agents fundamentally lack the ability to achieve disease control and cytokine therapy with interleukin-2 has an unacceptably high – for...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Adv Med Oncol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4346213/ https://ncbi.nlm.nih.gov/pubmed/25755683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834014566619 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|